EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tryptanthrin Down-Regulates Oncostatin M by Targeting GM-CSF-Mediated PI3K-AKT-NF-κB Axis

Na-Ra Han, Hi-Joon Park, Seong-Gyu Ko iD, Phil-Dong Moon

Nutrients · 2024

DOI: 10.3390/nu16234109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Na-Ra Han und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea. Hauptthemen laut MEDLINE: Granulocyte-Macrophage Colony-Stimulating Factor, Proto-Oncogene Proteins c-akt, NF-kappa B, Oncostatin M. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT), National Research Foundation of Korea (NRF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Oncostatin M (OSM) is involved in several inflammatory responses. Tryptanthrin (TRYP), as a natural alkaloid, is a bioactive compound derived from indigo plants. Objectives/ Methods: The purpose of this study is to investigate the potential inhibitory activity of TRYP on OSM release from neutrophils using neutrophils-like differentiated (d)HL-60 cells and neutrophils from mouse bone marrow.

Results

The results showed that TRYP reduced the production and mRNA expression levels of OSM in the granulocyte–macrophage colony-stimulating factor (GM-CSF)-stimulated neutrophils-like dHL-60 cells. In addition, TRYP decreased the OSM production levels in the GM-CSF-stimulated neutrophils from mouse bone marrow. TRYP inhibited the phosphorylation of phosphatidylinositol 3-kinase (PI3K), AKT, and nuclear factor (NF)-κB in the GM-CSF-stimulated neutrophils-like dHL-60 cells.

Conclusions

Therefore, these results reveal for the first time that TRYP inhibits OSM release via the down-regulation of PI3K-AKT-NF-κB axis from neutrophils, presenting its potential as a therapeutic agent for inflammatory responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Granulocyte-Macrophage Colony-Stimulating FactorProto-Oncogene Proteins c-aktNF-kappa BOncostatin MSignal TransductionNeutrophilsDown-RegulationPhosphatidylinositol 3-KinasesQuinazolinesAnimalsHumansMiceHL-60 CellsPhosphorylation

Stichwörter der Autor:innen

inflammationneutrophilsoncostatin Mtryptanthrin

Substanzen

tryptanthrineGranulocyte-Macrophage Colony-Stimulating FactorProto-Oncogene Proteins c-aktNF-kappa BOncostatin MPhosphatidylinositol 3-KinasesQuinazolines

Autor:innen und Institutionen

  • College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
  • Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
  • Department of Anatomy & Information Sciences, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
  • Department of Preventive Medicine, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
  • Center for Converging Humanities, Kyung Hee University, Seoul 02447, Republic of Korea.

ORCID-Profile: Seong-Gyu Ko

Förderung

  • National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT)
  • National Research Foundation of Korea (NRF)

Zitieren

APA

Han, N. R., Park, H. J., Ko, S. G., & Moon, P. D. (2024). Tryptanthrin Down-Regulates Oncostatin M by Targeting GM-CSF-Mediated PI3K-AKT-NF-κB Axis. Nutrients. https://doi.org/10.3390/nu16234109

Vancouver

Han NR, Park HJ, Ko SG, Moon PD. Tryptanthrin Down-Regulates Oncostatin M by Targeting GM-CSF-Mediated PI3K-AKT-NF-κB Axis. Nutrients. 2024. doi:10.3390/nu16234109

BibTeX
@article{Han2024,
  author = {Han, Na-Ra and Park, Hi-Joon and Ko, Seong-Gyu and Moon, Phil-Dong},
  title = {Tryptanthrin Down-Regulates Oncostatin M by Targeting GM-CSF-Mediated PI3K-AKT-NF-κB Axis},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16234109}
}
Kostenlos starten →